Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christophe Pannecouque

Showing results (171-180 of 428) with videos related to

Pageof 43
Sort By:
Antiviral Chemistry & Chemotherapy|December 26, 2003
Synthesis and antiviral activity of 1,3-disubstituted uracils against HIV-1 and HCMVTokumi Maruyama, Shigetada Kozai, Tetsuo Yamasaki, et al.
Journal of Medicinal Chemistry|September 16, 2005
Synthesis, anti-HIV activity, and metabolic stability of new alkenyldiarylmethane HIV-1 non-nucleoside reverse transcriptase inhibitorsBo-Liang Deng, Tracy L Hartman, Robert W Buckheit, et al.
Journal of Medicinal Chemistry|November 5, 2024
Expanding the Solvent/Protein Region Occupation of the Non-Nucleoside Reverse Transcriptase Inhibitor Binding Pocket for Improved Broad-Spectrum Anti-HIV-1 Efficacy: from Rigid Phenyl-Diarylpyrimidines to Flexible Hydrophilic Piperidine-DiarylpyrimidinesWen-Juan Huang, Christophe Pannecouque, Erik De Clercq, et al.
Bioorganic & Medicinal Chemistry|October 19, 2013
Design, synthesis and biological evaluation of 3-benzyloxy-linked pyrimidinylphenylamine derivatives as potent HIV-1 NNRTIsDiwakar Rai, Wenmin Chen, Ye Tian, et al.
Bioorganic & Medicinal Chemistry|November 17, 2023
In situ click chemistry-based discovery of 1,2,3-triazole-derived diarylpyrimidines as novel HIV-1 NNRTIs by exploiting the tolerant region I in binding pocketYanying Sun, Da Feng, Zhenzhen Zhou, et al.
Acta Pharmaceutica Sinica. B|March 15, 2024
Structure-based design and optimization lead to the identification of novel dihydrothiopyrano[3,2-<i>d</i>]pyrimidine derivatives as potent HIV-1 inhibitors against drug-resistant variantsZhao Wang, Heng Zhang, Zhen Gao, et al.
Viruses|December 28, 2021
Deciphering the Role of Extracellular Vesicles Derived from ZIKV-Infected hcMEC/D3 Cells on the Blood-Brain Barrier SystemAntonios Fikatas, Jonas Dehairs, Sam Noppen, et al.
European Journal of Medicinal Chemistry|April 29, 2014
Discovery of novel diarylpyrimidines as potent HIV NNRTIs via a structure-guided core-refining approachXiao Li, Wenmin Chen, Ye Tian, et al.
Chemical & Pharmaceutical Bulletin|August 5, 2005
Nonnucleoside HIV-1 reverse-transcriptase inhibitors, part 5. Synthesis and anti-HIV-1 activity of novel 6-naphthylthio HEPT analoguesGuang-Fu Sun, Xu-Xiang Chen, Fen-Er Chen, et al.
AIDS (London, England)|December 4, 2004
Multiple mutations in human immunodeficiency virus-1 integrase confer resistance to the clinical trial drug S-1360Valery Fikkert, Anneleen Hombrouck, Barbara Van Remoortel, et al.
Pageof 43

Showing results (171-180 of 428) with videos related to

Sort By:
Pageof 43
Antiviral Chemistry & Chemotherapy|December 26, 2003
Synthesis and antiviral activity of 1,3-disubstituted uracils against HIV-1 and HCMVTokumi Maruyama, Shigetada Kozai, Tetsuo Yamasaki, et al.
Journal of Medicinal Chemistry|September 16, 2005
Synthesis, anti-HIV activity, and metabolic stability of new alkenyldiarylmethane HIV-1 non-nucleoside reverse transcriptase inhibitorsBo-Liang Deng, Tracy L Hartman, Robert W Buckheit, et al.
Journal of Medicinal Chemistry|November 5, 2024
Expanding the Solvent/Protein Region Occupation of the Non-Nucleoside Reverse Transcriptase Inhibitor Binding Pocket for Improved Broad-Spectrum Anti-HIV-1 Efficacy: from Rigid Phenyl-Diarylpyrimidines to Flexible Hydrophilic Piperidine-DiarylpyrimidinesWen-Juan Huang, Christophe Pannecouque, Erik De Clercq, et al.
Bioorganic & Medicinal Chemistry|October 19, 2013
Design, synthesis and biological evaluation of 3-benzyloxy-linked pyrimidinylphenylamine derivatives as potent HIV-1 NNRTIsDiwakar Rai, Wenmin Chen, Ye Tian, et al.
Bioorganic & Medicinal Chemistry|November 17, 2023
In situ click chemistry-based discovery of 1,2,3-triazole-derived diarylpyrimidines as novel HIV-1 NNRTIs by exploiting the tolerant region I in binding pocketYanying Sun, Da Feng, Zhenzhen Zhou, et al.
Acta Pharmaceutica Sinica. B|March 15, 2024
Structure-based design and optimization lead to the identification of novel dihydrothiopyrano[3,2-<i>d</i>]pyrimidine derivatives as potent HIV-1 inhibitors against drug-resistant variantsZhao Wang, Heng Zhang, Zhen Gao, et al.
Viruses|December 28, 2021
Deciphering the Role of Extracellular Vesicles Derived from ZIKV-Infected hcMEC/D3 Cells on the Blood-Brain Barrier SystemAntonios Fikatas, Jonas Dehairs, Sam Noppen, et al.
European Journal of Medicinal Chemistry|April 29, 2014
Discovery of novel diarylpyrimidines as potent HIV NNRTIs via a structure-guided core-refining approachXiao Li, Wenmin Chen, Ye Tian, et al.
Chemical & Pharmaceutical Bulletin|August 5, 2005
Nonnucleoside HIV-1 reverse-transcriptase inhibitors, part 5. Synthesis and anti-HIV-1 activity of novel 6-naphthylthio HEPT analoguesGuang-Fu Sun, Xu-Xiang Chen, Fen-Er Chen, et al.
AIDS (London, England)|December 4, 2004
Multiple mutations in human immunodeficiency virus-1 integrase confer resistance to the clinical trial drug S-1360Valery Fikkert, Anneleen Hombrouck, Barbara Van Remoortel, et al.
Pageof 43